Cambridge Investment Research Advisors, Inc. Verastem, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	SELL	$0.92 - $11.16 $44,202 - $536,193	-48,046 Reduced 82.13%	10,455 $0
Q2 2022 Jul 13, 2022	SELL	$1.02 - $1.83 $2,387 - $4,284	-2,341 Reduced 3.85%	58,501 $67,000
Q1 2022 May 12, 2022	SELL	$1.06 - $2.1 $2,045 - $4,053	-1,930 Reduced 3.07%	60,842 $85,000
Q3 2021 Nov 02, 2021	BUY	$2.54 - $4.07 $8,890 - $14,245	3,500 Added 5.9%	62,772 $193,000
Q2 2021 Aug 10, 2021	SELL	$2.57 - $4.85 $16,306 - $30,773	-6,345 Reduced 9.67%	59,272 $241,000
Q1 2021 May 07, 2021	BUY	$1.9 - $2.82 $15,580 - $23,124	8,200 Added 14.28%	65,617 $162,000
Q4 2020 Feb 04, 2021	SELL	$1.15 - $2.4 $5,750 - $12,000	-5,000 Reduced 8.01%	57,417 $122,000
Q3 2020 Oct 29, 2020	SELL	$1.11 - $1.68 $3,526 - $5,337	-3,177 Reduced 4.84%	62,417 $75,000
Q2 2020 Jul 27, 2020	BUY	$1.69 - $4.2 $7,228 - $17,963	4,277 Added 6.98%	65,594 $112,000
Q1 2020 May 08, 2020	BUY	$1.26 - $3.38 $15,498 - $41,574	12,300 Added 25.09%	61,317 $161,000
Q4 2019 Feb 04, 2020	BUY	$0.86 - $1.44 $860 - $1,440	1,000 Added 2.08%	49,017 $65,000
Q3 2019 Nov 06, 2019	BUY	$1.21 - $1.59 $7,260 - $9,540	6,000 Added 14.28%	48,017 $58,000
Q2 2019 Aug 15, 2019	BUY	$1.25 - $3.14 $3,812 - $9,577	3,050 Added 7.83%	42,017 $0
Q1 2019 May 08, 2019	BUY	$2.79 - $4.09 $108,717 - $159,375	38,967 New	38,967 $0

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$1.19 Million
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$254,879
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$106,199
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$15,850
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$5,702
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.12B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account